Bicycle Therapeutics (BCYC) Treasury Shares (2018 - 2026)

Bicycle Therapeutics has reported Treasury Shares for 6 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 45.12% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 45.12% YoY), and the FY2025 full-year result was $1.5 million, up 129.46% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.8 million, up from $1.5 million in the prior quarter.
• The five-year high for Treasury Shares was $2.8 million in Q1 2026, with the low at $187725.0 in Q1 2022.
• Historically, Treasury Shares has averaged $891627.2 across 5 years, with a median of $674262.0 in 2024.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 141.08% — and 2026, when it jumped 45.12%.
• Bicycle Therapeutics' Treasury Shares stood at $187725.0 in 2022, then jumped by 74.11% to $326848.0 in 2023, then surged by 106.29% to $674262.0 in 2024, then soared by 129.46% to $1.5 million in 2025, then jumped by 79.81% to $2.8 million in 2026.
• The last three Treasury Shares figures came in at $2.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.